GMO COMPASS - Information on genetically modified organisms
  Mar 12, 2010 | 9:30 pm
Site Search
Searches all of GMO-Compass in an instant
The setting-up of this website was financially supported by the European Union within the European Commission’s Sixth Framework Programme from 1 January 2005 until 28 February 2007.

The European Commission and other EU agencies are not responsible for the content.
See what’s what.
The GMO Food Database
The GMO Food Database.
You want to know for which food products or plants gene technology plays a role?

Then enter here the name of a plant, foodstuff, ingredient or additive:

Database search
All database entries in overview:
Plants
Foodstuffs
Ingredients and additives
Additives according to E numbers
Enzymes


Please note that the GMO Compass Database currently is being expanded and updated. Please check back for new entries.

Newsletter
Sign up to receive regular updates on GM food quality and safety.
To change or cancel your subscription, please enter your email above.
Contact
Comments, suggestions or questions?
Please contact us at info@gmo-compass.org
Change font size
1 2 3

News Messages


November 2007 December 2007
14 December 2007
BASF expects EU approval of Amflora within weeks

The chemical group BASF has expressed optimism that within a few weeks the European Commission may approve the genetically modified “Amflora” potato to be grown in Europe. In early December, Hans Kast, Managing Director of BASF Plant Science, spoke with journalists in Brussels and stated the expectation the decision be made in any case early enough for the growing season of 2008.

Developed by BASF, Amflora possesses an improved starch profile. It contains only amylopectin instead of a mixture of amylopectin and amylase and therefore is particularly valuable for the paper and textile industry.

Since EU ministers did not reach a qualified majority on the application last July, the decision now is the responsibility of the Commission and an approval would be the first of its kind in the European Union since 1998. During the last weeks, some EU Member States have called for a review of the decision-making process.

A spokesperson for BASF Plant Science advised that there would be enough seed potatoes on stock to secure commercial cultivation. In Europe, the planting of potatoes is begun in the early spring, with precise dates depending on regional climates. However, since farmers decide on their production program usually during winter, an approval that arrives after February would be too late to influence the coming season. Moreover, in Germany, for example, the intention to grow genetically modified plants must be announced in the national register three months in advance of any actual planting.

While awaiting speedy approval for Amflora, BASF announced new field trials with two other genetically modified potatoes. The releases will take place at four locations in the German federal states of Brandenburg, Mecklenburg-Western Pomerania and Saxony-Anhalt between 2008 and 2012. In one case, the modified potato is similar to Amflora but is based on a different conventional variety. The other potato line contains genes from wild potatoes found in South America. These genes make its carrier tolerant to a fungus that destroys a significant portion of the potato crop each year. Known as phytophthora, this fungus is the target of most fungicide used in potato cultivation today. In recent years, field trials with the two varieties have taken place in several European countries including Germany and the Netherlands. The new locations in the eastern states of Germany must be authorised by the Federal Office of Consumer Protection and Food Safety (BVL) and the process of mandatory public hearings has begun.

Overview: Genetically modified potatoes
GMO Safety: Phytophthora infestans
10 December 2007
Australia: The cultivation of GM rapeseed to begin in 2008
Approval for the planting of genetically modified rapeseed in Australia will take effect at the beginning of next year. The federal states of New South Wales and Victoria have revoked moratoria that had applied since 2004 to the cultivation of GM plants. However, the cultivation of GM rapeseed must be approved by local authorities and the freedom of choice of consumers must be maintained by the strict separation of GM of conventional rapeseed.

The two states are responsible for one half of the 1.5 million tonnes of rapeseed produced in Australia each year. Stating that Australia thereby may resume its competitive role in the international agricultural market, farmers’ representatives welcomed the decision. Canada may serve as a model: the nation is the largest producer of this crop world-wide and cultivates eighty per cent of its rapeseed fields with a GM herbicide-resistant variety.

Several lines of GM rapeseed had been approved years ago in Australia, and industrial seed producers have announced the launch in March of new varieties that display resistance to “Roundup” herbicides. Such GM lines may facilitate a significant economy of measures against weeds.

Last year, 38 per cent of Australian rapeseed was exported to Europe. Nonetheless, a representative of the Australian Oilseeds Federation stated the low interest of his association in the European market. Since export quantities to Europe fluctuate greatly, this disinterest was attributed to the unpredictability of trade relations.

In the four remaining Australian states, moratoria on the cultivation of GM plants remain in force.

Global Cultivations Exceed 100 Million Hectares in 2006
Rapeseed
06 December 2007
German authority clears MON810

Genetically modified Bt maize MON810 may be sold again in Germany for commercial cultivation. The licensee Monsanto has received the all-clear from the competent authority, the Federal Office of Consumer Protection and Food Safety (BVL) on Thursday. In April 2007, the BVL suspended authorisation of the market placement of MON810 and asked Monsanto for a plan to monitor the environmental effects of the cultivation of insect-tolerant Bt maize. After months of negotiations, the BVL now has accepted an implementation plan submitted by Monsanto. Measures have been agreed upon that include the observation of the effects that the cultivation of MON810 has on biodiversity. This monitoring will be conducted by an existing network of public institutions, scientists and associations and will address soil life as well as species such as butterflies, bees, common birds and wild game. Last year, 2,680 hectares of MON810 were grown in Germany and Monsanto expects this area to expand significantly in the coming season.

BVL press release, 06/12/2007
Monsanto monitoring plan
BVL asks for MON810 monitoring

Messages 2010
March
February
January
Stories
The issue of contradictory results of biosafety studies
Opposition decreasing or acceptance increasing?
An overview of European consumer polls on attitudes to GMOs
German ban on MON810 maize: will the courts now decide?
China plans to invest in GM crops R&D and consumer education
"Find the wisdom to allow GM technology to flourish"
Results of the GMO Compass snapshot poll
Genetic engineering of cut flowers
Preliminary studies raise hopes: Golden Rice works well!
GMO labelling of foodstuffs produced from animals – the discussion continues
GM Crops in Australia – will the moratoria end?
International study: consumers would buy GM products
GM plants no problem for the honey industry
Are GMOs Fuelling the Brazilian Future?
Latest Eurobarometer: Yes to Biotech – No to GM Food
Barley, Beer and Biotechnology
Farm Fresh Pharmaceuticals
Study: GM Soy Dangerous for Newborns?
Safety evaluation: GM peas in Australia with unexpected side-effects
The western corn rootworm: A pest coming to a maize field near you
Plants for the Future
XML News Feed
Merge the latest news messages from GMO-Compass in shortened form onto your news reader or web log.
GMO-Compass news feeds use XML formatting and require RSS 2.0 (really simple syndication). This standard format allows diverse applications to easily exchange and integrate data from the internet.
Download

© 2010 by GMO Compass. All rights reserved. | Imprint | website created by webmotive